HIV testing and treatment among tuberculosis patients --- Kenya, 2006--2009

Morbidity and Mortality Weekly Report

Volumn 59, Issue 46, 2010, Pages 1514-1517

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

COTRIMOXAZOLE;

ARTICLE; CD4 LYMPHOCYTE COUNT; HEALTH CARE FACILITY; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KENYA; MASS SCREENING; PREVALENCE; TUBERCULOSIS;

CD4 LYMPHOCYTE COUNT; HEALTH FACILITIES; HEALTH POLICY; HIV INFECTIONS; HUMANS; KENYA; MASS SCREENING; POPULATION SURVEILLANCE; PREVALENCE; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION; TUBERCULOSIS;

EID: 78649715045     PISSN: 01492195     EISSN: 1545861X     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. CDC. Mortality among patients with tuberculosis and associations with HIV status--United States, 1993-2008. MMWR 2010;59:1509-13.
2. CDC. Provider-initiated HIV testing and counseling of TB patients--Livingstone District, Zambia, September 2004-December 2006. MMWR 2008;57:285-9.
3. World Health Organization. Interim policy on collaborative TB/HIV activities. Geneva, Switzerland: World Health Organization; 2004. Available at http://whqlibdoc.who.int/hq/2004/who_htm_tb_2004.330_eng.pdf. Accessed November 22, 2010.
4. World Health Organization. Guidelines on co-trimoxazole prophylaxis for HIV-related infections among children, adolescents, and adults: recommendations for a public health approach. Geneva, Switzerland: World Health Organization; 2006. Available at http://www.who.int/entity/hiv/pub/guidelines/ctxguidelines.pdf. Accessed November 22, 2010.
5. World Health Organization. Rapid advice: antiretroviral therapy for HIV infection in adolescents and adults. Geneva, Switzerland: World Health Organization; 2009. Available at http://www.who.int/entity/hiv/pub/arv/rapid_advice_art.pdf. Accessed November 22, 2010.
6. Chakaya JM, Mansoer JR, Scano F, et al. National scale-up of HIV testing and provision of HIV care to tuberculosis patients in Kenya. Int J Tuberc Lung Dis 2008;12:424-9.
7. Republic of Kenya Ministry of Health. National AIDS and STI Control Programme: guidelines for HIV testing in clinical settings. Nairobi, Kenya: Republic of Kenya Ministry of Health; 2004.
8. Teck R, Ascurra O, Gomani P, et al. WHO clinical staging of HIV infection and disease, tuberculosis, and eligibility for antiretroviral treatment: relationship to CD4 lymphocyte counts. Int J Tuberc Lung Dis 2005;9:258-62.
9. Abdool Karim SS, Naidoo K, Grobler A, et al. Timing of initiation of antiretroviral drugs during tuberculosis therapy. N Engl J Med 2010;362:697-706.
10. Huerga H, Spillan H, Guerrero W, Odongo A, Varaine F. Impact of introducing human immunodeficiency virus testing, treatment, and care in a tuberculosis clinic in rural Kenya. Int J Tuberc Lung Dis 2010;14:611-5.